• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Constitutes
© 2025 Longbridge|Disclaimer

Event Tracking

Dec22
AstraZeneca's Enhertu Receives Breakthrough Therapy Designation for Early Breast Cancer
07:30
Cailian Press: With the dramatic change in the form of warfare, military stocks are becoming super growth stocks, and Palantir's stock price has doubled within the year
07:22
AstraZeneca's Imfinzi and ceralasertib combination therapy fails in late-stage non-small cell lung cancer
07:21
Tesla releases annual humanoid robot report, reiterates three core challenges
07:10
AstraZeneca Announces Ceralasertib Shows Good Tolerance in Treating Non-Small Cell Lung Cancer
07:06
Italian antitrust authority fines Apple 98 million euros for alleged abuse of market dominance
07:03